BLOG

Doctors' Point

We frequently receive inquiries at our cosmetic surgery outpatient clinic asking, “Is it possible to donate blood after a Re2O (Rituo; Japanese name: Bunaju) treatment?”

 

To get straight to the point, individuals who have received Re2O (Bunaju) are advised to refrain from donating blood. This is not primarily due to the downtime associated with the procedure or the act of injection itself, but rather because Re2O is a human-derived extracellular matrix (ECM) preparation.

 

In this article, I will provide a clear explanation—from the perspective of a cosmetic surgeon—of the criteria for re2o blood donation, its theoretical background, and key practical considerations.

 

Please note that this does not mean you cannot donate blood simply because you have undergone cosmetic medical procedures. This is a precautionary measure based on the safety principles governing transfusion medicine involving human-derived products, designed to ensure the safety of both patients and donors.

 

We will outline the latest thinking on this topic, including questions we actually receive in cosmetic surgery clinics and points that are often misunderstood.

What Is Re2O (Bunaju)? Its Role in Cosmetic Surgery

Re2O is an ECM skin booster marketed in South Korea; in Japan, a formulation with the same ingredients is sold under the name “BNAJU.” While the name and packaging differ, the contents are identical. A key feature of this product is that it acts directly on the skin’s environment itself using ECM (extracellular matrix) derived from human dermis.

 

Rather than directly adding volume like hyaluronic acid, this is an “environmental improvement” approach that is expected to enhance skin firmness, elasticity, radiance, and reduce fine lines and pores, while improving overall skin quality.

 

In cosmetic surgery, we recommend Re2O (Bunaju) as a skin booster option while prioritizing downtime management, managing patient expectations, ensuring safety, and carefully assessing patient suitability.

 

During a consultation at a cosmetic surgery clinic, it is common to discuss how much improvement in skin quality to aim for as part of a treatment plan, including combinations with other treatments (such as hyaluronic acid injections, botulinum toxin, and energy-based devices).

Can You Donate Blood After a Re2O Treatment? — The Conclusion and the Rationale Behind It

Regarding whether it is safe to donate blood after a Re2O treatment, the recommended policy is to “refrain from donating blood after the treatment.” The primary reason for this is that Re2O (Bunaju) is a human-derived ECM preparation.

 

In blood transfusion medicine, the principle of prioritizing the safety of the recipient above all else is adopted, taking into account the possibility that even a theoretically minimal risk may exist. For this reason, it is standard practice to exercise caution during the blood donation screening process for individuals with a history of using human-derived products.

 

This policy does not imply that Re2O (Bunaju) itself is dangerous; rather, it is an institutional safeguard designed to maximize the safety of blood transfusions. The final decision on whether a donation is acceptable is based on the latest standards of the Japanese Red Cross Society, as well as the medical interview and screening conducted on the day of donation. Therefore, it is advisable for those wishing to donate blood to share this information with the staff before the procedure.

Why Should People Refrain from Donating Blood When Using Human-Derived ECM Preparations?

Donated blood is transfused to patients with compromised immune systems, those with serious illnesses, and patients undergoing surgery. In the field of transfusion medicine, a safety philosophy of “avoiding even the tiniest theoretical risk as much as possible” has been upheld for many years.

 

For products made from human-derived materials, strict measures are in place regarding donor selection, screening for infectious diseases, and safety management during the manufacturing process, and safety standards are continuously being improved. Even so, blood transfusion medicine remains a field committed to “striving to achieve zero,” and the precautionary principle is widely adopted.

 

For this reason, when donating blood after Re2O treatment, donors are advised to refrain from donating not because of “risks to blood products,” but from the perspective of “patient safety in transfusion settings.” Understanding that this is a procedural requirement of the transfusion system—separate from the merits or demerits of the cosmetic surgery treatment itself—will make it easier to make an informed decision.

Misconceptions About Safety and “Danger”: A Cosmetic Surgeon’s Perspective

Re2O (Bunaju) is supplied as a pharmaceutical product for use in medical institutions under appropriate quality control. The simplistic notion that “it’s dangerous because it’s derived from humans” is incorrect. In the field of cosmetic surgery, techniques involving human-derived tissues are used across various specialties. Treatment plans are tailored to each individual patient following a process that includes an assessment of indications, contraindications, risk disclosure, and informed consent.

 

Restrictions on blood donation are institutional rules designed to improve the safety of transfusion medicine; they are a separate issue from the quality assessment and clinical utility of blood products.

"If I donate even once, does that mean I can't donate blood anymore?" — The verification process

With regard to Re2O (Bunaju), it is common for manufacturers and medical institutions to advise patients to “refrain from donating blood.” If you wish to continue donating blood in the future, be sure to inform the staff of your intention during the pre-treatment consultation.

 

Since the final decision on eligibility is based on the latest guidelines from the Japanese Red Cross Society and the assessment conducted on the day of the appointment, it is important to check the official website or contact the clinic for the most up-to-date information. At cosmetic surgery clinics, we can work with you to explore alternative procedures or adjust your schedule based on your life plans (such as blood donation, pregnancy plans, or upcoming international travel).

Differences from Other Treatments (Hyaluronic Acid, Botulinum Toxin, Rejuran)

Hyaluronic acid and botulinum toxin products are generally not considered subject to blood donation restrictions based on the fact that they are “human-derived.” In contrast, Re2O (Bunaju) differs significantly in that it uses human-derived ECM. Additionally, Rejuran (PN) contains salmon-derived DNA components and is not human-derived. During cosmetic surgery consultations, we provide comprehensive recommendations that take into account the impact of these differences in raw materials and manufacturing backgrounds on blood donation and other life events.

How to Interpret "Before & After" Images: Don't Base Your Judgment Solely on Numbers and Photos

The “Before & After” results for skin boosters can vary depending on shooting conditions, lighting, the time elapsed since treatment, and whether other treatments were used concurrently. In particular, when there are factors related to decisions outside the scope of treatment—such as donating blood after Re2O treatment—it is important to consider not only the visible changes but also the consistency of the product’s ingredients, blood donation regulations, and future plans.

 

Work with your cosmetic surgeon to identify the best solution by clearly articulating your goals, limitations, and priorities.

A Decision-Making Framework for People Who Value Blood Donation (As Applied in Cosmetic Surgery)

• Clarifying Objectives: Visualizing the Priorities of Improving Skin Condition and Continuing to Donate Blood

• Identifying Options: Comparing alternatives to Re2O (Bunaju), such as other skin boosters, skincare products, and energy devices

• Review of the Terms and Conditions: Familiarize yourself in advance with the Japanese Red Cross Society’s latest standards, medical questionnaire items, and the screening process

• Scheduling Optimization: If you have a blood donation scheduled, you can adjust the timing of your treatment or receive suggestions for alternative options.

• Risks and Expected Outcomes: Evaluate the onset and duration of effects, downtime, and cost-effectiveness from both quantitative and qualitative perspectives

• Recording and Sharing: Record medical history and medications taken, and share this information with the blood donation center to avoid any misunderstandings.

Frequently Asked Questions (FAQ)

Q. Regarding Re2O and blood donation: I’d like to continue donating blood as a hobby—is it okay for me to undergo the procedure?

A. If you wish to continue donating blood in the future, be sure to inform your doctor of this intention before the procedure. Since Re2O (Bunaju) is a human-derived ECM preparation, it is generally recommended that you refrain from donating blood. Cosmetic surgery clinics can offer suggestions regarding alternative procedures or rescheduling.

Q. A family member might need a blood transfusion. I’d like to help out as a donor myself.

A. If this is a possibility, please consult with us before your Re2O treatment, keeping in mind that blood donation policies apply. The final decision will be based on the latest guidelines from the Japanese Red Cross Society and the screening conducted on the day of your appointment. During your cosmetic surgery consultation, we will incorporate this prerequisite into your treatment plan.

Q. Is it treated the same way at Bunaju?

A. Yes. The Korean name "Re2O" and the Japanese name "Bunaju" refer to the same medication, and the guidelines regarding blood donation are the same. Similar information is provided in the informational materials from cosmetic surgery clinics.

Checklist for Consulting a Cosmetic Surgery Clinic

• First, share whether or not you intend to continue donating blood

• Verification of whether the formulation to be used is of human origin (Re2O/Bunaju is human-derived ECM)

• The Feasibility of Balancing Treatment Efficacy, Duration, and Treatment Frequency with the Blood Donation Schedule

• Provision of the most up-to-date instructions and consent forms based on the standards of the Japanese Red Cross Society

• Whether alternative treatments (e.g., non-human-derived skin boosters, energy devices) can be proposed

• Follow-up Support System for Cosmetic Surgery (Inquiry Desk, Follow-up Care, Provision of Medical Records)

Summary

Re2O (Bunaju) is a skin booster that targets the ECM, which forms the foundation of the skin; however, because it is a human-derived product, patients are advised to refrain from donating blood after treatment. This is a precautionary measure taken to prioritize the safety of blood transfusion recipients and does not imply that the product itself is dangerous. If you wish to continue donating blood, it is important to consult with your cosmetic surgeon before the procedure and, if necessary, consider alternative treatment options. Choose a treatment that aligns with your lifestyle and values, and proceed with the procedure only after you are fully satisfied with your decision.

 

▷ Rituo Re2O (Bunaju) Treatment Page

▷ Counseling Appointment Page